N Norton

Analysis of 10 independent samples provides evidence for association between schizophrenia and a SNP flanking fibroblast growth factor receptor 2

M C O'Donovan, M J Owen, T G Schulze, 2009, Molecular Psychiatry.

A promoter polymorphism in the monoamine oxidase A gene and its relationships to monoamine metabolite concentrations in CSF of healthy volunteers.

M J Owen, M. Owen, N. Norton, 2000, Journal of psychiatric research.

Evidence for rare and common genetic risk variants for schizophrenia at protein kinase C, alpha

D. Rujescu, G. Kirov, D. Grozeva, 2010, Molecular Psychiatry.

Meta-analysis of 32 genome-wide linkage studies of schizophrenia

E M Wijsman, G Kalsi, T Sigmundsson, 2009, Molecular Psychiatry.

Support for genetic variation in neuregulin 1 and susceptibility to schizophrenia

M C O'Donovan, A Preece, N. Williams, 2003, Molecular Psychiatry.

Identification in 2 independent samples of a novel schizophrenia risk haplotype of the dystrobrevin binding protein gene (DTNBP1).

M J Owen, A Preece, G. Kirov, 2004, Archives of general psychiatry.